TriSalus Life Sciences, Inc. TLSI Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $56.55M+172% | $20.79M-9.8% | $23.04M-14.2% | $26.84M+101% | $13.35M+50.4% | ||
| $22.34M-1.1% | $22.58M+6.9% | $21.12M+0.4% | $21.04M+4.3% | $20.17M+6.2% | ||
| $3.78M+22.8% | $3.08M-6.1% | $3.28M-13.9% | $3.81M-8.5% | $4.16M+2.8% | ||
| $68.14M+111% | $32.24M-3.3% | $33.33M-12.5% | $38.08M+51.8% | $25.1M+21.4% | ||
| $1.94M+7.4% | $1.81M-1.0% | $1.83M+6.7% | $1.71M-13.1% | $1.97M+17.9% | ||
| $70.98M+101% | $35.33M-3.1% | $36.46M-11.7% | $41.32M+44.3% | $28.63M+19.4% | ||
| $4.23M+41.0% | $3M-20.7% | $3.78M+98.9% | $1.9M-32.2% | $2.81M+23.4% | ||
| $11.79M+2.5% | $11.5M+5.4% | $10.91M+17.0% | $9.32M-20.7% | $11.75M+14.9% | ||
| $33.08M+0.1% | $33.05M+0.9% | $32.76M+1.5% | $32.27M+1.8% | $31.7M— | ||
| $58.17M-15.9% | $69.19M+9.5% | $63.19M+4.0% | $60.74M-3.6% | $63M+26.3% | ||
| 400M0.0% | 400M0.0% | 400M0.0% | 400M0.0% | 400M+13,333,233% | ||
| -$329.04M+0.5% | -$330.58M-3.0% | -$320.97M-7.6% | -$298.21M-2.9% | -$289.92M-3.7% | ||
| $12.81M+138% | -$33.86M-26.7% | -$26.73M-37.6% | -$19.42M+43.5% | -$34.37M-32.7% | ||
| $70.98M+101% | $35.33M-3.1% | $36.46M-11.7% | $41.32M+44.3% | $28.63M+19.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TriSalus Life Sciences, Inc.'s total assets?
- TriSalus Life Sciences, Inc. (TLSI) holds $71.0M in total assets, up 148.0% year over year.
- How much debt does TriSalus Life Sciences, Inc. have?
- TriSalus Life Sciences, Inc. carries $33.1M in total debt against $12.8M of shareholders' equity, a debt-to-equity ratio of 2.58.
- How much cash does TriSalus Life Sciences, Inc. have?
- TriSalus Life Sciences, Inc. holds $56.6M in cash and equivalents.
- Can TriSalus Life Sciences, Inc. cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does TriSalus Life Sciences, Inc.'s balance sheet data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
